Summary
Intravenous (IV) insulin is currently the standard of care but requires frequent monitoring and can cause excess hypoglycemia. This article presents results from a pilot study to determine the feasibility, efficacy, and safety of IV exenatide in hyperglycemic cardiac intensive care unit patients [Intravenous Exenatide in Coronary Intensive Care Unit Patients; NCT00736229].
- Insulin
- Diabetes Mellitus
- Diabetes & Endocrinology Clinical Trials
- © 2011 MD Conference Express
Tools
IV Exenatide Has the Same Efficacy as Insulin in C ICU Patients, without Inducing Hypoglycemia
Permalink:
Table of contents
Cited By...
- No citing articles found.